DK0723444T3 - Levobupivacain, som er egnet til behandling af kronisk smerte - Google Patents

Levobupivacain, som er egnet til behandling af kronisk smerte

Info

Publication number
DK0723444T3
DK0723444T3 DK94929595.0T DK94929595T DK0723444T3 DK 0723444 T3 DK0723444 T3 DK 0723444T3 DK 94929595 T DK94929595 T DK 94929595T DK 0723444 T3 DK0723444 T3 DK 0723444T3
Authority
DK
Denmark
Prior art keywords
levobupivacaine
pct
treatment
chronic pain
sec
Prior art date
Application number
DK94929595.0T
Other languages
English (en)
Inventor
Hazel Judith Bardsley
Laurence Mather
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10743430&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0723444(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Application granted granted Critical
Publication of DK0723444T3 publication Critical patent/DK0723444T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
DK94929595.0T 1993-10-13 1994-10-13 Levobupivacain, som er egnet til behandling af kronisk smerte DK0723444T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use

Publications (1)

Publication Number Publication Date
DK0723444T3 true DK0723444T3 (da) 1997-12-29

Family

ID=10743430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929595.0T DK0723444T3 (da) 1993-10-13 1994-10-13 Levobupivacain, som er egnet til behandling af kronisk smerte

Country Status (16)

Country Link
US (1) US5955479A (da)
EP (1) EP0723444B1 (da)
JP (1) JPH09503777A (da)
KR (1) KR100343314B1 (da)
CN (1) CN1074919C (da)
AT (1) ATE154758T1 (da)
AU (1) AU692477B2 (da)
CA (1) CA2173208C (da)
DE (1) DE69403969T2 (da)
DK (1) DK0723444T3 (da)
ES (1) ES2105766T3 (da)
GB (1) GB9321061D0 (da)
GR (1) GR3024787T3 (da)
HK (1) HK1006421A1 (da)
NO (1) NO309304B1 (da)
WO (1) WO1995010276A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821588B1 (en) * 1995-04-13 2003-06-18 Darwin Discovery Limited Levobupivacaine and its use as an anaesthetic in pregnant women
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
JP4521117B2 (ja) * 1997-07-21 2010-08-11 ブルース・エイチ・レヴィン 偏頭痛、群発性頭痛、緊張性頭痛、血管疾患に伴う頭痛、耳鳴りまたは筋肉性頭痛を治療するための医薬
PT998287E (pt) * 1997-07-22 2003-09-30 Darwin Discovery Ltd Utilizacao de levobupivacaina
AU735588B2 (en) 1997-09-18 2001-07-12 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
ES2384094T3 (es) 1997-11-14 2012-06-29 Pacira Pharmaceuticals, Inc. Producción de liposomas multivesiculares
DE69819770T2 (de) * 1997-11-19 2004-09-23 Darwin Discovery Ltd., Slough Anästhetikum
JP2002520120A (ja) 1998-07-17 2002-07-09 スカイファーマ インコーポレーテッド 封入物質の制御放出のための生分解性組成物
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
NZ533436A (en) 2001-11-14 2007-10-26 Alza Corp Catheter injectable depot compositons and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR20050038008A (ko) 2002-07-31 2005-04-25 알자 코포레이션 주사용 저장형 조성물 및 이의 용도
DK1539101T3 (da) 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
DE102008037682A1 (de) * 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CA3048485C (en) * 2016-12-26 2022-07-19 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2023215604A1 (en) 2022-05-05 2023-11-09 Pfof Llc Anesthetic nerve block and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use
ITTO20010597A1 (it) * 2001-06-20 2002-12-20 Plaset Spa Pompa per liquidi, in particolare pompa centrifuga per apparecchi elettrodomestici.

Also Published As

Publication number Publication date
KR100343314B1 (ko) 2003-02-19
ATE154758T1 (de) 1997-07-15
CA2173208C (en) 2007-01-30
HK1006421A1 (en) 1999-02-26
AU7859394A (en) 1995-05-04
JPH09503777A (ja) 1997-04-15
NO961478D0 (no) 1996-04-12
NO961478L (no) 1996-06-11
DE69403969D1 (de) 1997-07-31
EP0723444B1 (en) 1997-06-25
GR3024787T3 (en) 1998-01-30
EP0723444A1 (en) 1996-07-31
ES2105766T3 (es) 1997-10-16
GB9321061D0 (en) 1993-12-01
DE69403969T2 (de) 1997-11-20
CN1074919C (zh) 2001-11-21
CA2173208A1 (en) 1995-04-20
NO309304B1 (no) 2001-01-15
CN1133009A (zh) 1996-10-09
US5955479A (en) 1999-09-21
AU692477B2 (en) 1998-06-11
WO1995010276A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69616376T2 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
BR0213100A (pt) Combinações para o tratamento de distúrbios imuniinflamatórios
DK0751778T3 (da) Anvendelse af deuteriumforarmet vand til fremstilling af hygiejniske og kosmetiske præparater
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATE293972T1 (de) Behandlung von chronischen schmerzen
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
SE9101341D0 (sv) New medicinal use
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
NO984190L (no) FremgangsmÕte for behandling av insomnia
RU93048255A (ru) Способ лечения вибрационной болезни
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору